Seehra Jasbir 4
4 · Keros Therapeutics, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-23+125,000→ 125,000 totalExercise: $63.61Exp: 2034-02-22→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The reported transaction involves the Reporting Person's receipt of an option grant. The shares subject to the option shall vest upon the achievement of specified performance criteria, subject to the Reporting Person continuing to provide service through each such date.